Vergoeding 2015-2019 voor ATC-subgroep A10BJ : Glucagonachtig peptide-1-agonisten (glp-1-agonisten)

  • Raming voor de totale Zvw-populatie
  2015 2016 2017 2018 2019
A10BJ01 Exenatide (Bydureon ®) 1.310.600 1.155.200 998.240 879.410 727.830
A10BJ02 Liraglutide (Victoza ®) 12.925.100 12.153.100 11.946.100 13.629.900 13.761.500
A10BJ03 Lixisenatide (Lyxumia ®) 37.597 35.703 51.653 90.202 83.267
A10BJ05 Dulaglutide (Trulicity ®) 150.760 622.090 1.699.500 2.757.000 2.635.600
A10BJ06 Semaglutide (Ozempic ®) . . . 379.730 9.247.600
Totaal 14.424.057 13.966.093 14.695.493 17.736.242 26.455.797